Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

CUSIP: 162828206

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
61,355,717
Total 13F shares
31,915,849
Share change
+20,744,290
Total reported value
$128,901,911
Put/Call ratio
822%
Price per share
$4.04
Number of holders
83
Value change
+$88,225,568
Number of buys
56
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 162828206?
CUSIP 162828206 identifies CKPT - Checkpoint Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock (CKPT) as of Q1 2025

As of 31 Mar 2025, Checkpoint Therapeutics, Inc. - Common Stock (CKPT) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,915,849 shares. The largest 10 holders included Beryl Capital Management LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TORONTO DOMINION BANK, GLAZER CAPITAL, LLC, VANGUARD GROUP INC, BARCLAYS PLC, GABELLI FUNDS LLC, GABELLI & Co INVESTMENT ADVISERS, INC., Groupe la Francaise, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND. This page lists 83 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.